Therefore, the aim of this study was to develop an HTS protocol using endometriosis-patient-derived immortalized endometrial stromal cell lines for the identification of non-estrogen-receptor-targeting compounds that have translational potential as therapeutics for endometriosis. The gene discussed is ESR1; the disease is endometriosis.